Published in Arch Dis Child on March 01, 1990
Growth hormone deficiency in children with chromosomal abnormalities. Arch Dis Child (1990) 0.75
Clinical and chromosomal studies of the 18q- syndrome. J Pediatr (1971) 1.69
Growth hormone, suspected gonadotrophin deficiency, and ring 18 chromosome. Arch Dis Child (1988) 1.39
Ring 21 chromosome: the mild end of the phenotypic spectrum. Clin Genet (1986) 1.19
A male infant with holoprosencephaly, associated with ring chromosome 21. Clin Genet (1987) 1.15
Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance. Thromb Haemost (2001) 2.16
Plasma protein S deficiency in familial thrombotic disease. Blood (1984) 1.82
Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab (2000) 1.78
Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP) Thromb Haemost (1999) 1.69
Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism (1982) 1.65
Binding of disease-associated prion protein to plasminogen. Nature (2000) 1.64
The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur J Pediatr (1995) 1.61
Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol (1993) 1.55
Salivary cortisol levels throughout childhood and adolescence: relation with age, pubertal stage, and weight. Pediatr Res (1995) 1.54
Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor. J Thromb Haemost (2009) 1.52
Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br J Haematol (2000) 1.51
Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study. J Pediatr (2003) 1.44
Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits. Shock (1998) 1.43
CYP21 mutations in simple virilizing congenital adrenal hyperplasia. J Mol Med (Berl) (2001) 1.39
Intermittent microalbuminuria in children with type 1 diabetes mellitus without clinical evidence of nephropathy. Eur J Pediatr (1988) 1.39
Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes (2001) 1.32
Effect of whole-body x-ray irradiation on phospholipids of rat liver particulate fractions. Arch Biochem Biophys (1965) 1.31
Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion (2001) 1.24
Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem (1995) 1.22
Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem (1995) 1.17
Behavioral effects of prenatal versus postnatal androgen excess in children with 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab (2000) 1.17
Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy. Pediatr Res (1983) 1.16
A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion (1998) 1.15
Endorectal ultrasound: instrumentation and clinical aspects. Int J Colorectal Dis (1986) 1.10
Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab (1996) 1.06
Clinical, biochemical and molecular genetic data in five children with Gitelman's syndrome. Horm Metab Res (2001) 1.04
The alpha-keto acids of branched-chain amino acids: simplified derivatization for physiological samples and complete separation as quinoxalinols by packed column gas chromatography. Anal Biochem (1980) 1.03
Identification and quantitation of protein S in human platelets. Blood (1985) 1.02
Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med (1991) 1.02
Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A. Thromb Haemost (2000) 1.01
Monitoring the bioavailability of FEIBA with a thrombin generation assay. J Thromb Haemost (2003) 1.00
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. J Clin Invest (1998) 0.99
Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr (1995) 0.99
Genotyping of the prion protein gene at codon 129. Acta Neuropathol (1999) 0.99
Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin Exp Immunol (2005) 0.97
Endosonography of pararectal lymph nodes. In vitro and in vivo evaluation. Dis Colon Rectum (1990) 0.97
Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res (1988) 0.97
Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb (2003) 0.97
Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. N Engl J Med (1998) 0.96
Evaluation of growth hormone release in children using arginine and L-dopa in combination. J Pediatr (1975) 0.96
Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical use. Vox Sang (2010) 0.96
FEIBA: mode of action. Haemophilia (2004) 0.96
Success and relapse rate after treatment of cryptorchidism with intranasal LHRH. Acta Paediatr Scand (1985) 0.94
Cerebral edema complicating therapy for diabetic ketoacidosis. Diabetes (1976) 0.94
Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol (Oxf) (2001) 0.93
Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up. J Pediatr Endocrinol Metab (2008) 0.92
BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation. Hamostaseologie (2012) 0.92
Liver involvement in cystic fibrosis. A report of 9 cases. Helv Paediatr Acta (1978) 0.92
Musculoskeletal and functional muscle-bone analysis in children with rheumatic disease using peripheral quantitative computed tomography. Osteoporos Int (2004) 0.90
Glycemic control in early IDDM. The Wisconsin Diabetes Registry. Diabetes Care (1992) 0.90
Low intelligence but not attention deficit hyperactivity disorder is associated with resistance to thyroid hormone caused by mutation R316H in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab (1994) 0.90
A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity. Vox Sang (2007) 0.90
Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone. Horm Res Paediatr (2010) 0.89
Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood (1986) 0.88
Development of a plasma- and albumin-free recombinant von Willebrand factor. Hamostaseologie (2009) 0.88
Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency. Clin Chem (1998) 0.87
The determination of von Willebrand factor activity by collagen binding assay. Haemophilia (1998) 0.87
Partnership and sexuality in adult female patients with congenital adrenal hyperplasia. First results of a cross-sectional quality-of-life evaluation. J Steroid Biochem Mol Biol (1993) 0.86
Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J Clin Endocrinol Metab (2001) 0.86
Thrombin generation assay and other universal tests for monitoring haemophilia therapy. Haemophilia (2004) 0.86
Toxic psychosis from transdermal scopolamine in a child. Lancet (1986) 0.86
Feminization in a galactosemic girl in the presence of hypergonadotropic hypogonadism. Acta Endocrinol Suppl (Copenh) (1986) 0.85
Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography. J Clin Endocrinol Metab (2005) 0.85
Final height and predicted height in boys with untreated constitutional growth delay. Eur J Pediatr (1995) 0.85
An update on clinical and basic aspects of the protein C anticoagulant pathway. Trends Cardiovasc Med (2011) 0.85
Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood (1993) 0.84
Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life. Horm Res Paediatr (2010) 0.84
Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation. Thromb Haemost (1996) 0.84
In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease. Blood (1997) 0.84
Seizures, psychosis and coma: severe course of hashimoto encephalopathy in a six-year-old girl. Neuropediatrics (2007) 0.84
Young adults born small for gestational age: is reduced baroreceptor sensitivity a risk factor for hypertension? Clin Cardiol (2006) 0.84
Phenotypic expression of murine hemophilia. Thromb Haemost (1999) 0.83
Serum concentrations of LH and FSH in the healthy newborn. Eur J Endocrinol (2000) 0.83
Prostaglandin induced, stress related, phospholipid changes in blood and brain. Physiol Chem Phys (1974) 0.83
Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin. FEBS Lett (1995) 0.83
Long-chain bases of brain and spinal cord of rabbits. J Neurochem (1967) 0.83
Quantitative immunoblotting assay of blood coagulation factor XII. Thromb Res (1986) 0.83
Pertussis toxin sensitive G-proteins are not involved in the mitogenic signaling pathway of insulin-like growth factor-I in normal rat kidney epithelial (NRKE) cells. Regul Pept (1996) 0.83
C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma? Transfusion (2001) 0.83
Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol (2002) 0.83
Modulation of factor VIII-specific memory B cells. Haemophilia (2010) 0.83
Changes in BMI and management of patients with childhood onset growth hormone deficiency in the transition phase. Exp Clin Endocrinol Diabetes (2012) 0.83
Vaccine tolerance in steroid substituted patients with congenital adrenal hyperplasia. Eur J Med Res (1997) 0.82
Effects of human alpha-1-acid glycoprotein on aminonucleoside-induced minimal change nephrosis in rats. Nephron (1999) 0.82
[Vasodepressor syncopes in metastasizing laryngeal cancer. Combination therapy using an AV sequential pacemaker and ephedrine]. Acta Med Austriaca (1986) 0.82
Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia A. Lab Anim (2010) 0.82
[Diagnostic significance of serum bile acids]. Schweiz Med Wochenschr (1975) 0.82
True hermaphroditism in a 46,XY individual, caused by a postzygotic somatic point mutation in the male gonadal sex-determining locus (SRY): molecular genetics and histological findings in a sporadic case. Am J Hum Genet (1993) 0.82
Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin. Vox Sang (2008) 0.82
Fc function of a new intravenous immunoglobulin product: IGIV 10% triple virally inactivated solution. Vox Sang (2006) 0.81
Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage. Cytotechnology (1999) 0.81
Cerebral edema in diabetic ketoacidosis. J Pediatr (1981) 0.81
Phospholipid composition of blood plasma, erythrocytes, and "ghosts" in sickle cell disease. Clin Chem (1977) 0.81
Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)--evaluation and follow up of 18 patients. Eur J Pediatr (1996) 0.81
Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI. Thromb Haemost (1988) 0.81
Age-related expression of the cellular prion protein in human peripheral blood leukocytes. Haematologica (2000) 0.81
Histocompatibility antigens in patients with cystic fibrosis and diabetes mellitus. J Pediatr (1984) 0.81
Danazol may cause female pseudohermaphroditism. Fertil Steril (1981) 0.80
Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease. Blood Coagul Fibrinolysis (1998) 0.80